These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22292162)

  • 1. Anticoagulant loses its lustre.
    Mullard A
    Lancet; 2012 Jan; 379(9813):301. PubMed ID: 22292162
    [No Abstract]   [Full Text] [Related]  

  • 2. Faculty of Consulting Physicians of South Africa (FCPSA): saving brain with dabigatran.
    Aalbers J; Hardy G
    Cardiovasc J Afr; 2012 Jul; 23(6):350-1. PubMed ID: 23091827
    [No Abstract]   [Full Text] [Related]  

  • 3. Dabigatran efficacy-safety assessment for stroke prevention in patients with atrial fibrillation.
    Eikelboom JW; Quinlan DJ; Connolly SJ; Hart RG; Yusuf S
    J Thromb Haemost; 2012 May; 10(5):966-8. PubMed ID: 22360879
    [No Abstract]   [Full Text] [Related]  

  • 4. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE; Lake JD
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract]   [Full Text] [Related]  

  • 5. Place of dabigatran in contemporary pharmacotherapy.
    Gums JG
    Pharmacotherapy; 2011 Apr; 31(4):335-7. PubMed ID: 21449622
    [No Abstract]   [Full Text] [Related]  

  • 6. Dabigatran: will it change clinical practice?
    Wartak SA; Bartholomew JR
    Cleve Clin J Med; 2011 Oct; 78(10):657-64. PubMed ID: 21968472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Edwards DB; Silverberg J
    Ann Intern Med; 2011 Apr; 154(8):570; author reply 570-1. PubMed ID: 21502658
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fewer strokes, lower mortality. Large general practice studies confirm good safety profile of dabigatran].
    Einecke D
    MMW Fortschr Med; 2014 Dec; 156(21-22):28, 30. PubMed ID: 25608388
    [No Abstract]   [Full Text] [Related]  

  • 9. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
    Nagarakanti R; Ezekowitz MD; Oldgren J; Yang S; Chernick M; Aikens TH; Flaker G; Brugada J; Kamensky G; Parekh A; Reilly PA; Yusuf S; Connolly SJ
    Circulation; 2011 Jan; 123(2):131-6. PubMed ID: 21200007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular thrombectomy for acute ischemic stroke patients anticoagulated with dabigatran.
    Müller P; Topakian R; Sonnberger M; Nußbaumer K; Windpessl M; Eder V; Nesser HJ; Trenkler J; Haring HP
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2257-9. PubMed ID: 23921437
    [No Abstract]   [Full Text] [Related]  

  • 11. [New oral anticoagulant agents: the quandary of anticoagulation in the elderly].
    Páramo JA
    Med Clin (Barc); 2013 Oct; 141(8):346-8. PubMed ID: 23831406
    [No Abstract]   [Full Text] [Related]  

  • 12. Dabigatran and mechanical valves: less effective and more risky than warfarin.
    Prescrire Int; 2013 May; 22(138):128. PubMed ID: 23819180
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Shah SV; Gage BF
    Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dabigatran: a new oral anticoagulant.
    Golembiewski JA
    J Perianesth Nurs; 2011 Dec; 26(6):420-3. PubMed ID: 22099138
    [No Abstract]   [Full Text] [Related]  

  • 15. New medicines - urgent need to assess outcomes in special groups.
    Martin JH; Coory MD
    Med J Aust; 2012 Apr; 196(7):433. PubMed ID: 22509864
    [No Abstract]   [Full Text] [Related]  

  • 16. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
    Eikelboom JW; Connolly SJ; Hart RG; Wallentin L; Reilly P; Oldgren J; Yang S; Yusuf S
    J Am Coll Cardiol; 2013 Sep; 62(10):900-8. PubMed ID: 23770182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New oral anticoagulants are as safe in elderly patients as conventional drugs].
    Steurer J
    Praxis (Bern 1994); 2014 Aug; 103(17):1032. PubMed ID: 25146949
    [No Abstract]   [Full Text] [Related]  

  • 18. [Wünderlich syndrome in patient anticoagulated with dabigatran].
    de Gea-García JH; Alvarez M; Ruiz-Villa G; Jiménez-Parra JD
    Med Clin (Barc); 2013 Aug; 141(4):184-5. PubMed ID: 23369498
    [No Abstract]   [Full Text] [Related]  

  • 19. Next generation anticoagulants may push warfarin to the wayside.
    Kirsch B
    Manag Care; 2011 Feb; 20(2):33-6. PubMed ID: 21428128
    [No Abstract]   [Full Text] [Related]  

  • 20. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
    Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.